您的购物车当前为空
COX-2/HDAC6-IN-1 (Compound 11e) 是一种双重COX-2/HDAC6抑制剂,HDAC6 IC50为0.12 μM,COX-2 IC50为0.66 μM;该化合物可提高α-tubulin乙酰化水平,调控表观遗传基因表达,并抑制促炎介质(COX-2、IL-1β、IL-6和TNF-α)表达,同时促进Amyloid-β清除、减少Tau蛋白过度磷酸化,通过稳定MAP2维持神经元形态、调节突触素以保护突触完整性并恢复记忆相关基因表达,表现出神经保护活性,可改善Scopolamine诱导的阿尔茨海默病小鼠模型的学习和记忆能力,适用于阿尔茨海默病相关研究。
COX-2/HDAC6-IN-1 (Compound 11e) 是一种双重COX-2/HDAC6抑制剂,HDAC6 IC50为0.12 μM,COX-2 IC50为0.66 μM;该化合物可提高α-tubulin乙酰化水平,调控表观遗传基因表达,并抑制促炎介质(COX-2、IL-1β、IL-6和TNF-α)表达,同时促进Amyloid-β清除、减少Tau蛋白过度磷酸化,通过稳定MAP2维持神经元形态、调节突触素以保护突触完整性并恢复记忆相关基因表达,表现出神经保护活性,可改善Scopolamine诱导的阿尔茨海默病小鼠模型的学习和记忆能力,适用于阿尔茨海默病相关研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | COX-2/HDAC6-IN-1 (Compound 11e) is a dual inhibitor targeting COX-2 and HDAC6 with an HDAC6 IC50 of 0.12 μM and a COX-2 IC50 of 0.66 μM. This compound enhances α-tubulin acetylation, regulates epigenetic gene expression, and inhibits the expression of pro-inflammatory mediators (COX-2, IL-1β, IL-6, and TNF-α). Additionally, COX-2/HDAC6-IN-1 promotes Amyloid-β clearance and reduces excessive phosphorylation of Tau protein. It supports neuronal morphology through MAP2 stabilization and maintains synaptic integrity by regulating synaptophysin, thereby restoring expression of memory-related genes. COX-2/HDAC6-IN-1 exhibits neuroprotective activity, improving learning and memory in Scopolamine-induced Alzheimer's disease mouse models. It is applicable for research related to Alzheimer's disease. |
| 靶点活性 | HDAC6:0.12 μM |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多